Research and Policy Repository

  • Author: Michal Mrug
Clear all

Sodium-glucose cotransporter-2 inhibitor therapy and longitudinal changes in kidney function among Veterans with autosomal dominant polycystic kidney disease

Abstract: Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are a pillar of kidney disease therapy, but their efficacy remains unknown in autosomal dominant …

Physical Health Peer reviewed

US Veterans Administration autosomal dominant polycystic kidney disease cohort: Demographic, comorbidity and key laboratory data characteristics

Abstract: BACKGROUND: We used the largest integrated US health care system, the Veterans Health Administration (VHA), to establish a robust resource for demographic, longitudinal …

Physical Health Peer reviewed